Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 0.77% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
Structured product status and remediation from the issuing vendor. Product-state explanations are always visible; large lists can be searched or downloaded.
The vendor explicitly identifies these products as affected by this CVE.
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
Patch availableA CWE-200: Exposure of Sensitive Information to an Unauthorized Actor vulnerability exists that could allow an attacker to access the system with elevated privileges when a privileged account clicks on a malicious URL that compromises the security token. Affected Products: AP7xxxx and AP8xxx with NMC2 (V6.9.6 or earlier), AP7xxx and AP8xxx with NMC3 (V1.1.0.3 or earlier), and APDU9xxx with NMC3 (V1.0.0.28 or earlier)
A CWE-200: Exposure of Sensitive Information to an Unauthorized Actor vulnerability exists that could allow an attacker to access the system with elevated privileges when a privileged account clicks on a malicious URL that compromises the security token. Affected Products: AP7xxxx and AP8xxx with NMC2 (V6.9.6 or earlier), AP7xxx and AP8xxx with NMC3 (V1.1.0.3 or earlier), and APDU9xxx with NMC3 (V1.0.0.28 or earlier)
The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may gain additional privileges.
A CWE-200: Exposure of Sensitive Information to an Unauthorized Actor vulnerability exists that could allow an attacker to access the system with elevated privileges when a privileged account clicks on a malicious URL that compromises the security token. Affected Products: AP7xxxx and AP8xxx with NMC2 (V6.9.6 or earlier), AP7xxx and AP8xxx with NMC3 (V1.1.0.3 or earlier), and APDU9xxx with NMC3 (V1.0.0.28 or earlier)
The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may gain additional privileges.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-200: Exposure of Sensitive Information to an Unauthorized Actor. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:HCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 28 Jan 2022 · Last source change 8 Sept 2025, 16:09 UTC · CWE-200 · Exposure of Sensitive Information to an Unauthorized Actor
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.